FEATURED EDITORIAL
The greying of cardiology: implications for management
Correspondence to:
Correspondence to:
Professor Nanette K Wenger
Emory University School of Medicine, 49 Jesse Hill Jr Drive, Atlanta, Georgia 30303, USA; nwenger{at}emory.edu
"The development of new therapies and devices should reflect the dominant population that will ultimately use themin the case of cardiovascular therapies and devices, this is exemplified by elderly patients"
This article has been cited by other articles:
-
Mayosi, B. M
(2007). Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa. Heart
93: 1176-1183
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
